[Chemotherapy of radically unresectible neuroblastoma in the 1st 18 months of life. Importance of quantitative determination of dopamine, vanilmandelic and homovanillic acids].
D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery / Q000652:urine; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004298:Dopamine / Q000652:urine*; D004359:Drug Therapy, Combination; D005260:Female; D006719:Homovanillic Acid / Q000652:urine*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery / Q000652:urine; D010648:Phenylacetates / Q000652:urine*; D014642:Vanilmandelic Acid / Q000652:urine*; D014750:Vincristine / Q000627:therapeutic use*
D010648:Phenylacetates; D014642:Vanilmandelic Acid; D014750:Vincristine; D003520:Cyclophosphamide; D004298:Dopamine; D006719:Homovanillic Acid
Zur Chemotherapie nicht radikal resezierbarer Neuroblastome in den ersten 18 Lebensmonaten. Bedeutung quantitativer Bestimmungen von Dopamin, Vanillinmandel- und Homovanillinsäure